Mologic seeks alternative to “relentless profiteering” of medical industry by providing affordable medical technology in poorer countries in £30m acquisition backed by Gates Foundation, Soros Economic Development Fund and others.
Social investors backing health and social care businesses see themselves as key partners – much more than just ‘bankers in sandals’ – as Covid-19 pressures refuse to abate. Catch up in the latest webinar from Pioneers Post and Good Finance.
C SUMMIT: Sanofi Espoir Foundation boss says the pandemic has confirmed its conviction that medicine and healthcare are not the full solution for global health challenges – while Repsol Foundation leader predicts a "time for doers".
How do social innovators turn crisis into opportunity? Three impact ventures share their experiences of adapting, pivoting and even expanding since the coronavirus outbreak.
The Ethiopian anaesthetist – who is providing the government with the country’s only advanced life support ambulances – on PPE challenges, facing possible bankruptcy, and why saving lives is non-negotiable.
A new wave of corporate social investors is drawing on the best of two worlds, philanthropy and corporate responsibility. A parent firm’s firepower brings advantages – but also challenges, as the Sanofi Espoir Foundation in France reveals.
Leading scientists at Imperial College London developing a Covid-19 vaccine have chosen a social enterprise structure for “maximum flexibility” and to remain affordable to the world’s poorest.
PLUS: Covid-19 announcements you may have missed; ADB Ventures tech fund raises first $50m; EU invests €1m in Oneplanetcrowd platform; grants for UK energy innovators; and more from the world of investing for good.
‘Father of impact investing’ argues pay-for-success model could deliver huge cost savings, while incentivising the rapid, entrepreneurial innovation needed to develop successful tests.
